EE9900387A - (E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraat - Google Patents
(E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraatInfo
- Publication number
- EE9900387A EE9900387A EEP199900387A EEP9900387A EE9900387A EE 9900387 A EE9900387 A EE 9900387A EE P199900387 A EEP199900387 A EE P199900387A EE P9900387 A EEP9900387 A EE P9900387A EE 9900387 A EE9900387 A EE 9900387A
- Authority
- EE
- Estonia
- Prior art keywords
- phenylpyrrolidin
- ylidenemethyl
- indole
- dichloro
- oxo
- Prior art date
Links
- VDIRQCDDCGAGET-DHZHZOJOSA-N 4,6-dichloro-3-[(e)-(2-oxo-1-phenylpyrrolidin-3-ylidene)methyl]-1h-indole-2-carboxylic acid Chemical compound OC(=O)C=1NC2=CC(Cl)=CC(Cl)=C2C=1\C=C(C1=O)/CCN1C1=CC=CC=C1 VDIRQCDDCGAGET-DHZHZOJOSA-N 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| PCT/EP1998/001146 WO1998039327A1 (fr) | 1997-03-05 | 1998-03-03 | Sel hydrate cristallin de sodium de l'acide (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ylidene methyle)-1h-indole-2-carboxylique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900387A true EE9900387A (et) | 2000-04-17 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900387A EE9900387A (et) | 1997-03-05 | 1998-03-03 | (E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraat |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (fr) |
| JP (1) | JP2001513796A (fr) |
| KR (1) | KR20000075907A (fr) |
| CN (1) | CN1249750A (fr) |
| AP (1) | AP9901637A0 (fr) |
| AR (1) | AR011178A1 (fr) |
| AU (1) | AU6825198A (fr) |
| BG (1) | BG103779A (fr) |
| BR (1) | BR9808305A (fr) |
| CA (1) | CA2282851A1 (fr) |
| CO (1) | CO4940415A1 (fr) |
| EA (1) | EA199900710A1 (fr) |
| EE (1) | EE9900387A (fr) |
| GB (1) | GB9704498D0 (fr) |
| HR (1) | HRP980114A2 (fr) |
| HU (1) | HUP0002109A2 (fr) |
| ID (1) | ID24207A (fr) |
| IL (1) | IL131489A0 (fr) |
| IS (1) | IS5166A (fr) |
| NO (1) | NO994303L (fr) |
| NZ (1) | NZ337315A (fr) |
| OA (1) | OA11154A (fr) |
| PE (1) | PE51399A1 (fr) |
| PL (1) | PL335652A1 (fr) |
| SK (1) | SK119699A3 (fr) |
| TR (1) | TR199902117T2 (fr) |
| WO (1) | WO1998039327A1 (fr) |
| YU (1) | YU43499A (fr) |
| ZA (1) | ZA981791B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX393950B (es) | 2017-06-12 | 2025-03-24 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/fr not_active Abandoned
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 EP EP98913613A patent/EP0966463A1/fr not_active Withdrawn
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/fr not_active Ceased
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000075907A (ko) | 2000-12-26 |
| CA2282851A1 (fr) | 1998-09-11 |
| GB9704498D0 (en) | 1997-04-23 |
| AP9901637A0 (en) | 1999-09-30 |
| HUP0002109A2 (hu) | 2001-04-28 |
| CO4940415A1 (es) | 2000-07-24 |
| NO994303L (no) | 1999-11-03 |
| IS5166A (is) | 1999-08-27 |
| ZA981791B (en) | 1999-09-03 |
| PL335652A1 (en) | 2000-05-08 |
| IL131489A0 (en) | 2001-01-28 |
| AU6825198A (en) | 1998-09-22 |
| NO994303D0 (no) | 1999-09-03 |
| HRP980114A2 (en) | 1998-12-31 |
| NZ337315A (en) | 2001-02-23 |
| EA199900710A1 (ru) | 2000-04-24 |
| BG103779A (en) | 2000-06-30 |
| JP2001513796A (ja) | 2001-09-04 |
| EP0966463A1 (fr) | 1999-12-29 |
| SK119699A3 (en) | 2000-05-16 |
| ID24207A (id) | 2000-07-13 |
| AR011178A1 (es) | 2000-08-02 |
| YU43499A (sh) | 2000-12-28 |
| PE51399A1 (es) | 1999-06-07 |
| BR9808305A (pt) | 2000-05-16 |
| TR199902117T2 (xx) | 2000-03-21 |
| WO1998039327A1 (fr) | 1998-09-11 |
| CN1249750A (zh) | 2000-04-05 |
| OA11154A (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0991641T3 (da) | Krystallinsk form af omeprazol-natriumsalt | |
| NO20013665L (no) | Kaliumsalt av (S)-omeprazol | |
| DE59912742D1 (de) | Substituierte pyrazolderivate | |
| EE200000720A (et) | Uus 3-arüül-2-hüdroksüpropaanhappe derivaat (I) | |
| DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
| NO20003451D0 (no) | 2,3-substituerte indolforbindelser som cox-2 inhibitorer | |
| NO20010331L (no) | Ftalazinderivater som fosfodiesterase 4-inhibitorer | |
| PT1032579E (pt) | Derivados de hidratos de carbono | |
| EE9900387A (et) | (E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraat | |
| FI950568A7 (fi) | 5-heteroaryyli-indolijohdannaiset | |
| NO996448D0 (no) | System for intervensjon av undervannsbrønner | |
| AU1817700A (en) | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 | |
| DE69824279D1 (de) | Stabilisiertes Natriumcarbonat-Peroxyhydrat | |
| HK1022899A (en) | Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid | |
| DE50004107D1 (de) | Natriumvalproat-granulat mit verringerter hygroskopizität | |
| DZ3463A1 (fr) | Cristaux d'inhibiteurs de l'echangeur sodium-hydrogene de type 1 | |
| NO20010972L (no) | System for overföring av datapakker | |
| DE69905397D1 (de) | Selektive inhibitoren des mmp-12 | |
| ATE414059T1 (de) | Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid | |
| SI0991641T1 (en) | Crystalline form of omeprazole sodium salt | |
| IT1303734B1 (it) | Forma cristallina del diclofenac sale sodico. |